报告３０例Ⅲ期原发性肝癌（其中６例合并门静脉癌栓）经股动脉穿刺肝动脉插管灌注化疗并栓塞治疗（ＴＡＣＥ）临床分析。经３８例次治疗后，３０例中１８例肿瘤缩小，其中３例缩小５０％以上；存活期＞６个月者１８例，其中＞１２个月者８例。分析认为，ＴＡＣＥ对不能手术切除的晚期肝癌有良好疗效；对伴有门静脉癌栓形成者也应积极栓塞治疗；正确识别肿瘤的供养动脉对预后有直接影响。 Thirty cases of stage III primary liver cancer (including 6 cases with portal vein tumor emboli) were treated with femoral artery puncture and hepatic artery catheterization chemotherapy and embolization (TACE). After 38 cases of treatment, 18 of the 30 cases had tumor shrinking, of which 3 cases shrank by more than 50%; 18 cases survived >6 months, including 8 cases >12 months. According to the analysis, TACE has good curative effect on advanced hepatocellular carcinoma that cannot be surgically removed; it should also be actively embolized for patients with portal vein tumor thrombus formation; correctly identifying the tumor’s feeding artery has a direct impact on prognosis.